| 1. Executive Summary |
| 2. Global Infertility Therapeutics Market Introduction |
| 2.1. Global Infertility Therapeutics Market – Taxonomy |
| 2.2. Global Infertility Therapeutics Market –Definitions |
| 2.2.1. By Drug Class |
| 2.2.2. By Route of Administration |
| 2.2.3. By Gender |
| 2.2.4. By Distribution Channels |
| 2.2.5. By Region |
| 3. Global Infertility Therapeutics Market Dynamics |
| 3.1. Drivers |
| 3.2. Restraints |
| 3.3. Opportunities/Unmet Needs of the Market |
| 3.4. Trends |
| 3.5. Global Infertility Therapeutics Market Dynamic Factors - Impact Analysis |
| 3.6. Global Infertility Therapeutics Market – Competition Landscape |
| 4. Global Infertility Therapeutics Market Analysis, 2017-2021 and Forecast, 2022-2028 |
| 4.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn) |
| 4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) |
| 4.3. Market Opportunity Analysis |
| 5. Global Infertility Therapeutics Market, By Drug Class, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn) |
| 5.1. Gonadotropin |
| 5.1.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn) |
| 5.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.1.3. Market Opportunity Analysis |
| 5.2. Aromatase Inhibitors |
| 5.2.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn) |
| 5.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.2.3. Market Opportunity Analysis |
| 5.3. Selective Estrogen Receptor Modulators (SERMs) |
| 5.3.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn) |
| 5.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.3.3. Market Opportunity Analysis |
| 5.4. Biguanides |
| 5.4.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn) |
| 5.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.4.3. Market Opportunity Analysis |
| 5.5. Others |
| 5.5.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn) |
| 5.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.5.3. Market Opportunity Analysis |
| 6. Global Infertility Therapeutics Market, By Route of Administration, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn) |
| 6.1. Oral |
| 6.1.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn) |
| 6.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.1.3. Market Opportunity Analysis |
| 6.2. Intravenous |
| 6.2.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn) |
| 6.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.2.3. Market Opportunity Analysis |
| 6.3. Subcutaneous |
| 6.3.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn) |
| 6.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.3.3. Market Opportunity Analysis |
| 6.4. Intramuscular |
| 6.4.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn) |
| 6.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.4.3. Market Opportunity Analysis |
| 7. Global Infertility Therapeutics Market, By Gender, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn) |
| 7.1. Men |
| 7.1.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn) |
| 7.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.1.3. Market Opportunity Analysis |
| 7.2. Women |
| 7.2.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn) |
| 7.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.2.3. Market Opportunity Analysis |
| 8. Global Infertility Therapeutics Market, By Distribution Channels, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn) |
| 8.1. Hospital Pharmacies |
| 8.1.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn) |
| 8.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.1.3. Market Opportunity Analysis |
| 8.2. Retail Pharmacies |
| 8.2.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn) |
| 8.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.2.3. Market Opportunity Analysis |
| 8.3. Online Pharmacies |
| 8.3.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn) |
| 8.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.3.3. Market Opportunity Analysis |
| 9. Global Infertility Therapeutics Market Forecast, By Region, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn) |
| 9.1. North America |
| 9.1.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn) |
| 9.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 9.1.3. Market Opportunity Analysis |
| 9.2. Europe |
| 9.2.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn) |
| 9.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 9.2.3. Market Opportunity Analysis |
| 9.3. Asia-Pacific |
| 9.3.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn) |
| 9.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 9.3.3. Market Opportunity Analysis |
| 9.4. Latin America |
| 9.4.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn) |
| 9.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 9.4.3. Market Opportunity Analysis |
| 9.5. Middle East and Africa |
| 9.5.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn) |
| 9.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 9.5.3. Market Opportunity Analysis |
| 9.6. Global Infertility Therapeutics Market - Opportunity Analysis Index, By Drug Class, By Route of Administration, By Gender, By Distribution Channels, and Region, 2022-2028 |
| 10. North America Infertility Therapeutics Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn) |
| 10.1. Drug Class Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
| 10.1.1. Gonadotropin |
| 10.1.2. Aromatase Inhibitors |
| 10.1.3. Selective Estrogen Receptor Modulators (SERMs) |
| 10.1.4. Biguanides |
| 10.1.5. Others |
| 10.2. Route of Administration Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
| 10.2.1. Oral |
| 10.2.2. Intravenous |
| 10.2.3. Subcutaneous |
| 10.2.4. Intramuscular |
| 10.3. Gender Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
| 10.3.1. Men |
| 10.3.2. Women |
| 10.4. Distribution Channels Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
| 10.4.1. Hospital Pharmacies |
| 10.4.2. Retail Pharmacies |
| 10.4.3. Online Pharmacies |
| 10.5. Country Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%) |
| 10.5.1. USA |
| 10.5.2. Canada |
| 10.6. North America Infertility Therapeutics Market - Opportunity Analysis Index, By Drug Class, By Route of Administration, By Gender, By Distribution Channels, and Country, 2022-2028 |
| 10.7. North America Infertility Therapeutics Market Dynamics – Trends |
| 11. Europe Infertility Therapeutics Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn) |
| 11.1. Drug Class Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
| 11.1.1. Gonadotropin |
| 11.1.2. Aromatase Inhibitors |
| 11.1.3. Selective Estrogen Receptor Modulators (SERMs) |
| 11.1.4. Biguanides |
| 11.1.5. Others |
| 11.2. Route of Administration Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
| 11.2.1. Oral |
| 11.2.2. Intravenous |
| 11.2.3. Subcutaneous |
| 11.2.4. Intramuscular |
| 11.3. Gender Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
| 11.3.1. Men |
| 11.3.2. Women |
| 11.4. Distribution Channels Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
| 11.4.1. Hospital Pharmacies |
| 11.4.2. Retail Pharmacies |
| 11.4.3. Online Pharmacies |
| 11.5. Country Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%) |
| 11.5.1. Germany |
| 11.5.2. UK |
| 11.5.3. France |
| 11.5.4. Spain |
| 11.5.5. Italy |
| 11.5.6. Russia |
| 11.5.7. Rest of Europe |
| 11.6. Europe Infertility Therapeutics Market - Opportunity Analysis Index, By Drug Class, By Route of Administration, By Gender, By Distribution Channels, and Country, 2022-2028 |
| 11.7. Europe Infertility Therapeutics Market Dynamics – Trends |
| 12. Asia-Pacific Infertility Therapeutics Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn) |
| 12.1. Drug Class Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
| 12.1.1. Gonadotropin |
| 12.1.2. Aromatase Inhibitors |
| 12.1.3. Selective Estrogen Receptor Modulators (SERMs) |
| 12.1.4. Biguanides |
| 12.1.5. Others |
| 12.2. Route of Administration Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
| 12.2.1. Oral |
| 12.2.2. Intravenous |
| 12.2.3. Subcutaneous |
| 12.2.4. Intramuscular |
| 12.3. Gender Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
| 12.3.1. Men |
| 12.3.2. Women |
| 12.4. Distribution Channels Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
| 12.4.1. Hospital Pharmacies |
| 12.4.2. Retail Pharmacies |
| 12.4.3. Online Pharmacies |
| 12.5. Country Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%) |
| 12.5.1. China |
| 12.5.2. India |
| 12.5.3. Japan |
| 12.5.4. ASEAN |
| 12.5.5. Australia & New Zealand |
| 12.5.6. Rest of Asia-Pacific |
| 12.6. Asia-Pacific Infertility Therapeutics Market - Opportunity Analysis Index, By Drug Class, By Route of Administration, by Drug Class, By Distribution Channels, and Country, 2022-2028 |
| 12.7. Asia-Pacific Infertility Therapeutics Market Dynamics – Trends |
| 13. Latin America Infertility Therapeutics Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn) |
| 13.1. Drug Class Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
| 13.1.1. Gonadotropin |
| 13.1.2. Aromatase Inhibitors |
| 13.1.3. Selective Estrogen Receptor Modulators (SERMs) |
| 13.1.4. Biguanides |
| 13.1.5. Others |
| 13.2. Route of Administration Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
| 13.2.1. Oral |
| 13.2.2. Intravenous |
| 13.2.3. Subcutaneous |
| 13.2.4. Intramuscular |
| 13.3. Gender Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
| 13.3.1. Men |
| 13.3.2. Women |
| 13.4. Distribution Channels Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
| 13.4.1. Hospital Pharmacies |
| 13.4.2. Retail Pharmacies |
| 13.4.3. Online Pharmacies |
| 13.5. Country Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%) |
| 13.5.1. Brazil |
| 13.5.2. Mexico |
| 13.5.3. Rest of Latin America |
| 13.6. Latin America Infertility Therapeutics Market - Opportunity Analysis Index, By Drug Class, By Route of Administration, By Gender, By Distribution Channels, and Country, 2022-2028 |
| 13.7. Latin America Infertility Therapeutics Market Dynamics – Trends |
| 14. Middle East and Africa Infertility Therapeutics Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn) |
| 14.1. Drug Class Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
| 14.1.1. Gonadotropin |
| 14.1.2. Aromatase Inhibitors |
| 14.1.3. Selective Estrogen Receptor Modulators (SERMs) |
| 14.1.4. Biguanides |
| 14.1.5. Others |
| 14.2. Route of Administration Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
| 14.2.1. Oral |
| 14.2.2. Intravenous |
| 14.2.3. Subcutaneous |
| 14.2.4. Intramuscular |
| 14.3. Gender Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
| 14.3.1. Men |
| 14.3.2. Women |
| 14.4. Distribution Channels Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
| 14.4.1. Hospital Pharmacies |
| 14.4.2. Retail Pharmacies |
| 14.4.3. Online Pharmacies |
| 14.5. Country Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%) |
| 14.5.1. Gulf CoDistribution Channels Council (GCC) Countries |
| 14.5.2. South Africa |
| 14.5.3. Rest of MEA |
| 14.6. MEA Infertility Therapeutics Market - Opportunity Analysis Index, By Drug Class, By Route of Administration, By Gender, By Distribution Channels, and Country, 2022-2028 |
| 14.7. MEA Infertility Therapeutics Market Dynamics – Trends |
| 15. Competition Landscape |
| 15.1. Strategic Dashboard of Top Market Players |
| 15.2. Company Profiles (Introduction, Financial Analysis, Key products, Key Developments, Strategies, and SWOT Analysis) |
| 15.2.1. Abbott Laboratories |
| 15.2.2. Takeda Pharmaceutical Company Limited |
| 15.2.3. Ferring Pharmaceuticals Inc. |
| 15.2.4. Pfizer Inc. |
| 15.2.5. Novartis International AG |
| 15.2.6. Bayer AG |
| 15.2.7. Teva Pharmaceticals Industries |
| 15.2.8. Merck & Co., Inc. |
| 15.2.9. Vitrolife AB |
| 15.2.10. MedGyn Products, Inc. |
| 16. Research Methodology |
| 17. Key Assumptions and Acronyms |
hghNorth America Got Significant Share
Infertility Therapeutics Market
Latin America
Europe
Asia Pacific
Middle East
North America
Key Features of the Reports
- The report provides granular level information about the market size, regional market share, historic market (2019-2023), and forecast (2024-2030)
- The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
- The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
- The report tracks recent innovations, key developments, and start-up details that are actively working in the market
- The report provides a plethora of information about market entry strategies, regulatory framework, and reimbursement scenario
Frequently Asked Questions
2021 is the base year and 2028 is the forecast year.
In our report, we provide 12-15 market players’ information into the report. However, based on the client’s request we will provide additional country and regional market players information as well.
- Abbott Laboratories
- Takeda Pharmaceutical Company Limited
- Ferring Pharmaceuticals Inc.
- Pfizer Inc.
- Novartis International AG
- Bayer AG
- Teva Pharmaceticals Industries
- Merck & Co., Inc.
- Vitrolife AB
- MedGyn Products, Inc.